Supplemental material
Bioengineered
Volume 13, 2022 - Issue 1
Open access
2,352
Views
17
CrossRef citations to date
0
Altmetric
Retraction
RETRACTED ARTICLE: miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
Yunguang Wanga Department of Critical Care Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China
, Fangfang Fenga Department of Critical Care Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China
, Wenfang Heb Department of Nephrology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, P.R China
, Lifang Sunc Department of Tuberculosis, Hangzhou Red Cross Hospital, Hangzhou, P.R China;d Department of Tuberculosis, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, P.R China
, Qiang Heb Department of Nephrology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, P.R ChinaCorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-3811-8226
& https://orcid.org/0000-0003-3811-8226
Juan Jinb Department of Nephrology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, P.R China
Pages 774-788
|
Received 14 Oct 2021, Accepted 27 Nov 2021, Published online: 05 Jan 2022
Related Research Data
miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.